Sanofi
450 hedge funds and large institutions have $10.1B invested in Sanofi in 2016 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 160 increasing their positions, 143 reducing their positions, and 40 closing their positions.
60% more capital inflows, than outflows
Capital inflows: $1.05B | Capital outflows: $660M
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
27% more call options, than puts
Call options by funds: $34.9M | Put options by funds: $27.4M
12% more repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 143
10% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 40
0.37% more ownership
Funds ownership: 9.29% → 9.66% (+0.37%)
0% more funds holding
Funds holding: 449 → 450 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$301M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$117M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$86.3M |
| 4 |
Dodge & Cox
San Francisco,
California
|
+$66.7M |
| 5 |
Hamlin Capital Management
New York
|
+$55.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$108M |
| 2 |
Barclays
London,
United Kingdom
|
-$97.2M |
| 3 |
CCM
Cutler Capital Management
Worcester,
Massachusetts
|
-$87.3M |
| 4 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
-$78.2M |
| 5 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$39.6M |
SNY Hedge Fund Activity: Q2 2016 in Review
450 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2016, worth a combined $10.1B — up 8.7% from $9.33B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new SNY positions and 40 closed out — a net gain of 4 holders — while 160 added to existing stakes and 143 trimmed.
The largest buyer was Boston Partners, adding an estimated $301M. The largest seller was Fidelity Investments, cutting an estimated $108M.
- 450 institutional investors held Sanofi (SNY) as of Q2 2016, up from 449 in Q1 2016.
- Funds reported $10.1B of Sanofi stock for Q2 2016, up 8.7% quarter-over-quarter.
- 44 funds opened new Sanofi positions in Q2 2016 and 40 closed out, a net change of +4 holders.
- The largest Sanofi buyer in Q2 2016 was Boston Partners, an estimated $301M added.
- The largest Sanofi seller in Q2 2016 was Fidelity Investments, an estimated $108M sold.
Based on aggregated 13F filings for Q2 2016.